tiprankstipranks
Chrysos Corp. Ltd. (AU:C79)
ASX:C79
Australian Market
Want to see AU:C79 full AI Analyst Report?

Chrysos Corp. Ltd. (C79) AI Stock Analysis

21 Followers

Top Page

AU:C79

Chrysos Corp. Ltd.

(Sydney:C79)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - Gpt-5.6Sol)
Rating:47Neutral
Price Target:
AU$7.50
▲(1.35% Upside)
Action:Reiterated
Date:08/19/26
The score is held down primarily by weakened financial performance (2026 revenue decline, sharp deterioration in gross/operating profitability, and persistently negative free cash flow) and an extremely expensive valuation (very high P/E with no dividend yield). Technicals provide partial support with an uptrend and positive MACD, but overbought signals temper the benefit.
Positive Factors
Recurring service-based revenue model
PhotonAssay deployments can generate recurring usage, support, maintenance and consumables revenue after installation. This service component may improve revenue visibility and deepen customer integration, although adoption and throughput remain execution-dependent.
Negative Factors
Revenue contraction and profitability deterioration
The sharp 2026 revenue reversal and collapse in gross and operating profitability weaken confidence in near-term scalability. Persistent weakness could limit funding capacity, delay customer deployments and challenge the sustainability of the business model.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring service-based revenue model
PhotonAssay deployments can generate recurring usage, support, maintenance and consumables revenue after installation. This service component may improve revenue visibility and deepen customer integration, although adoption and throughput remain execution-dependent.
Read all positive factors

Chrysos Corp. Ltd. (C79) vs. iShares MSCI Australia ETF (EWA)

Chrysos Corp. Ltd. Business Overview & Revenue Model

Company Description
Chrysos Corporation Limited is dedicated to creating and delivering advanced solutions for the mining industry. Established in 2016 and based in Adelaide, Australia, the company's flagship product is PhotonAssay. This innovative technology enables...
How the Company Makes Money
Chrysos makes money primarily by commercializing its PhotonAssay mineral analysis technology through service-based and equipment-related revenue. Key revenue streams include: (1) recurring fees from PhotonAssay deployments (typically structured as...

Chrysos Corp. Ltd. Financial Statement Overview

Summary
Mixed fundamentals: rapid revenue scaling through 2025 but a sharp reversal in 2026 (revenue down ~28%) and a major deterioration in gross profit and operating results. While the balance sheet is relatively resilient with moderate leverage and a sizable equity base, cash conversion is weak—free cash flow is consistently negative, raising ongoing funding/execution risk.
Income Statement
42
Neutral
Balance Sheet
67
Positive
Cash Flow
34
Negative
BreakdownJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue111.00K66.11M45.36M26.82M571.00K
Gross Profit-69.90M66.09M34.42M25.73M29.00K
EBITDA-60.92M17.34M11.68M5.09M2.16M
Net Income1.79M-8.22M-704.00K443.00K-3.94M
Balance Sheet
Total Assets306.47M264.31M243.26M163.41M144.09M
Cash, Cash Equivalents and Short-Term Investments25.89M21.52M61.07M53.36M92.10M
Total Debt64.33M25.41M6.67M14.28M8.82M
Total Liabilities108.79M66.01M44.99M39.18M21.77M
Stockholders Equity197.68M198.30M198.27M124.23M122.32M
Cash Flow
Free Cash Flow-25.42M-59.89M-56.23M-42.61M-25.67M
Operating Cash Flow13.55M8.83M3.63M4.65M1.41M
Investing Cash Flow-41.01M-68.72M-59.86M-47.26M-26.98M
Financing Cash Flow40.61M17.28M64.30M3.54M111.52M

Chrysos Corp. Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price7.40
Price Trends
50DMA
6.28
Positive
100DMA
6.39
Positive
200DMA
7.12
Negative
Market Momentum
MACD
0.17
Positive
RSI
49.15
Neutral
STOCH
26.62
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:C79, the sentiment is Negative. The current price of 7.4 is above the 20-day moving average (MA) of 7.21, above the 50-day MA of 6.28, and above the 200-day MA of 7.12, indicating a neutral trend. The MACD of 0.17 indicates Positive momentum. The RSI at 49.15 is Neutral, neither overbought nor oversold. The STOCH value of 26.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:C79.

Chrysos Corp. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
AU$652.73M40.735.34%18.83%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
55
Neutral
AU$28.97M-9.64-18.57%12.29%55.78%
47
Neutral
AU$793.58M446.100.90%-9.02%
46
Neutral
AU$11.77M-15.00-22.87%22.37%73.68%
42
Neutral
AU$22.92M-9.6667.50%-23.57%-38.10%
40
Underperform
AU$44.90M-5.14-23.77%10.62%41.67%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:C79
Chrysos Corp. Ltd.
6.87
0.25
3.78%
AU:3DP
Pointerra
0.03
-0.02
-42.86%
AU:AMX
Aerometrex Ltd.
0.30
0.12
66.67%
AU:VR1
Vection Technologies Ltd.
0.02
-0.04
-68.33%
AU:1CG
UUV Aquabotix Ltd.
0.01
0.00
0.00%
AU:NXL
Nuix Ltd.
2.00
-0.43
-17.70%

Chrysos Corp. Ltd. Corporate Events

UBS Group AG exits substantial holder position in Chrysos Corporation
Aug 18, 2026
UBS Group AG and its related bodies corporate have notified Chrysos Corporation Limited that they have ceased to be a substantial shareholder as of 14 August 2026. The change follows earlier disclosures in late July and indicates that UBS has redu...
Yarra Capital Group Exits Substantial Holding in Chrysos Corporation
Aug 14, 2026
Yarra Capital Management Limited and associated entities have ceased to be substantial shareholders in Chrysos Corporation Limited after a series of share sales concluded on 12 August 2026. The group collectively disposed of 106,947 Chrysos shares...
Chrysos posts record earnings as PhotonAssay uptake surges
Aug 10, 2026
Chrysos Corporation reported record FY26 results as rising global adoption of its PhotonAssayTM technology lifted revenue 33% to $88.1 million and EBITDA 68% to $27.2 million, expanding its EBITDA margin to 31%. The company processed a record 11.3...
Chrysos Flags Caveats Around FY26 Results and Gold Analysis Focus
Aug 10, 2026
Chrysos Corporation has released its FY26 financial results presentation, outlining its current activities and highlighting its core offering of accelerated, high-precision gold analysis technology. Aimed at a professional analyst audience, the ma...
Chrysos Corporation Positions FY26 Strategy for Global Growth
Aug 10, 2026
Chrysos Corporation’s FY26 annual report presents the company as positioned for growth, highlighting its global footprint, operational overview and a strategic journey built around milestones and evolving business models. The document outlin...
Chrysos swings to profit as PhotonAssay revenue surges
Aug 10, 2026
Chrysos Corporation Limited, a mining technology specialist, derives almost all of its revenue from PhotonAssay™ leases used in mineral assay, complemented by modest consumables sales and other income. Its core PhotonAssay™ offering pr...
Chrysos outlines governance and diversity framework
Aug 10, 2026
Chrysos Corporation Ltd has detailed its corporate governance framework, confirming full compliance with key principles on board oversight, director appointments and performance evaluation. The company maintains a formal Board Charter, written agr...
Chrysos Lodges 2026 Corporate Governance Statement and Appendix 4G
Aug 10, 2026
Chrysos Corporation Limited has lodged its corporate governance statement for the financial year ended 30 June 2026, making it available via its website in accordance with ASX Listing Rule 4.10.3. The statement, current as of 10 August 2026 and ap...
Chrysos Director’s Performance Rights Cut Following Equity Plan Adjustment
Aug 10, 2026
Chrysos Corporation Limited has reported a change in the interests of director Dirk Moore Treasure, reflecting an adjustment in his equity-based remuneration. The disclosure, lodged with the ASX, shows that Treasure retains substantial holdings in...
Chrysos Corrects Director Gregory Holt’s Recorded Shareholding
Aug 10, 2026
Chrysos Corporation Limited has disclosed a minor correction to the indirect shareholding of director Gregory Vincent Holt, held through the G.V. Holt Family Trust. Holt controls the voting rights of shares owned by Holt Family Investments (VIC) P...
Chrysos sets date for FY26 results and investor briefing
Jul 28, 2026
Chrysos Corporation Ltd. has scheduled the release of its full-year financial results for the year ended 30 June 2026 on 11 August 2026. Following the announcement, the company’s Managing Director and CEO, Dirk Treasure, and CFO, Brett Coven...
Chrysos Corrects Director Robert Adamson’s Reported Shareholding
Jul 3, 2026
Chrysos Corporation Limited has disclosed a change in director Robert Adamson’s relevant interests in the company’s securities, primarily reflecting a correction to his previously reported final shareholding. Following the adjustment, ...
Chrysos Chair Sells Shares to Cover Tax Liability, Retains Major Stake
Jul 2, 2026
Chrysos Corporation has disclosed that its chairman, Robert Adamson, sold 529,020 ordinary shares in the company to meet a personal tax liability linked to a previously reported restructuring of his shareholding arrangements. Following the transac...
Yarra Capital Group Builds 5.09% Substantial Stake in Chrysos
Jun 18, 2026
Yarra Capital Management, through a network of associated entities, has emerged as a substantial shareholder in Chrysos Corporation Limited after building a 5.09% stake. The group controls 5,931,961 ordinary fully paid shares, held via custodians ...
Chrysos Seeks ASX Quotation for Additional Ordinary Shares
May 24, 2026
Chrysos Corporation Limited has applied for quotation on the ASX of 12,500 ordinary fully paid shares, expanding the number of its listed securities. The newly quoted shares were issued on 21 May 2026, signalling a modest increase in the company&#...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2026